购物车
- 全部删除
- 您的购物车当前为空
Remetinostat (SHP-141) 是一种基于异羟肟酸的组蛋白脱乙酰酶抑制剂,可用于治疗皮肤 T 细胞淋巴瘤的研究。
Remetinostat (SHP-141) 是一种基于异羟肟酸的组蛋白脱乙酰酶抑制剂,可用于治疗皮肤 T 细胞淋巴瘤的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 170 | 现货 | |
5 mg | ¥ 397 | 现货 | |
10 mg | ¥ 636 | 现货 | |
25 mg | ¥ 1,270 | 现货 | |
50 mg | ¥ 1,970 | 现货 | |
100 mg | ¥ 3,230 | 现货 | |
200 mg | ¥ 4,530 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 437 | 现货 |
产品描述 | Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma. |
别名 | SHP-141 |
分子量 | 323.34 |
分子式 | C16H21NO6 |
CAS No. | 946150-57-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 150 mg/mL (463.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.